Qube Research & Technologies Ltd - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 179 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$2,838,674
+745.9%
127,010
+713.3%
0.01%
+600.0%
Q2 2023$335,588
-60.0%
15,616
-55.3%
0.00%
-75.0%
Q1 2023$838,786
+109.2%
34,964
+77.5%
0.00%
+33.3%
Q1 2022$401,000
-73.8%
19,699
-75.9%
0.00%
-75.0%
Q4 2021$1,529,000
+194.6%
81,876
+211.4%
0.01%
+71.4%
Q3 2021$519,000
+21.8%
26,295
+46.0%
0.01%
+40.0%
Q2 2021$426,000
-9.6%
18,015
-9.3%
0.01%
-28.6%
Q1 2021$471,000
-5.8%
19,859
-20.4%
0.01%0.0%
Q4 2020$500,000
+23.2%
24,955
+26.6%
0.01%
-46.2%
Q4 2019$406,00019,7080.01%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q2 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,887,332$27,819,0005.09%
SECTORAL ASSET MANAGEMENT INC 1,989,455$29,325,0003.11%
J. Goldman & Co LP 1,581,885$23,317,0001.63%
Eventide Asset Management 2,207,610$32,540,0001.20%
Rock Springs Capital Management LP 1,650,100$24,322,0000.88%
HAMILTON LANE ADVISORS LLC 114,489$2,0000.81%
RICE HALL JAMES & ASSOCIATES, LLC 565,942$8,342,0000.30%
HIGHLAND CAPITAL MANAGEMENT LP 337,429$4,973,0000.27%
Cortina Asset Management, LLC 393,436$5,799,0000.27%
Cormorant Asset Management, LP 250,000$3,685,0000.24%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders